Baidu
map

文件丨国务院印发《“十三五”深化医药卫生体制改革规划》

2017-01-09 中国政府网 中国政府网

经李克强总理签批,国务院日前印发《“十三五”深化医药卫生体制改革规划》(以下简称《规划》),部署加快建立符合国情的基本医疗卫生制度,推进医药卫生治理体系和治理能力现代化。《规划》指出,“十三五”时期是我国全面建成小康社会的决胜阶段,也是建立健全基本医疗卫生制度、推进健康中国建设的关键时期。要在巩固前期改革成果、认真总结经验的基础上,进一步统一思想、坚定信念、增强定力,进一步加强组织领导、制度创新和

经李克强总理签批,国务院日前印发《“十三五”深化医药卫生体制改革规划》(以下简称《规划》),部署加快建立符合国情的基本医疗卫生制度,推进医药卫生治理体系和治理能力现代化。

《规划》指出,“十三五”时期是我国全面建成小康社会的决胜阶段,也是建立健全基本医疗卫生制度、推进健康中国建设的关键时期。要在巩固前期改革成果、认真总结经验的基础上,进一步统一思想、坚定信念、增强定力,进一步加强组织领导、制度创新和重点突破,推动医改由打好基础转向提升质量、由形成框架转向制度建设、由单项突破转向系统集成和综合推进,用中国式办法破解医改这个世界性难题,为保障人民健康、促进经济社会发展增添新动力。

《规划》提出,要在5项制度建设上取得新突破。一是建立科学合理的分级诊疗制度。坚持居民自愿、基层首诊、政策引导、创新机制,到2020年,分级诊疗模式逐步形成,基本建立符合国情的分级诊疗制度。二是建立科学有效的现代医院管理制度。深化县级公立医院综合改革,加快推进城市公立医院综合改革。到2020年,基本建立具有中国特色的权责清晰、管理科学、治理完善、运行高效、监督有力的现代医院管理制度。三是建立高效运行的全民医疗保障制度。完善筹资机制,深化医保支付方式改革,加快推进基本医保全国联网和异地就医直接结算,提高大病保险对困难群众支付的精准性。四是建立规范有序的药品供应保障制度。实施药品生产、流通、使用全流程改革,建设符合国情的国家药物政策体系,理顺药品价格,保障药品安全有效、价格合理、供应充分。五是建立严格规范的综合监管制度。深化医药卫生领域“放管服”改革,构建多元化的监管体系,强化全行业综合监管,引导规范第三方评价和行业自律。

《规划》要求,要统筹推进相关领域改革,健全完善人才培养使用和激励评价机制,加快形成多元办医格局,推进公共卫生服务体系建设。要强化组织领导,强调责任落实,注重改革探索,强化科技支撑,推进国际合作,加强督查评估和宣传引导,确保各项措施落实到位。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1986989, encodeId=fe0c19869893e, content=<a href='/topic/show?id=006035295f4' target=_blank style='color:#2F92EE;'>#医药卫生体制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35295, encryptionId=006035295f4, topicName=医药卫生体制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Dec 01 20:30:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907285, encodeId=590e190e2857a, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Wed Apr 19 20:30:00 CST 2017, time=2017-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1995431, encodeId=a4701995431c2, content=<a href='/topic/show?id=6a1c2650946' target=_blank style='color:#2F92EE;'>#体制改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26509, encryptionId=6a1c2650946, topicName=体制改革)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Jun 05 11:30:00 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650209, encodeId=6c37165020996, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Tue Jul 25 14:30:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672445, encodeId=a9e616e24453d, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Sun Aug 20 00:30:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408813, encodeId=18191408813be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 11 13:30:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169282, encodeId=28341692829c, content=流通渠道和价格审查的监管很重要!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Tue Jan 10 09:56:45 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169170, encodeId=84181691e089, content=好消息,快点实施, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Jan 09 22:39:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1986989, encodeId=fe0c19869893e, content=<a href='/topic/show?id=006035295f4' target=_blank style='color:#2F92EE;'>#医药卫生体制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35295, encryptionId=006035295f4, topicName=医药卫生体制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Dec 01 20:30:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907285, encodeId=590e190e2857a, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Wed Apr 19 20:30:00 CST 2017, time=2017-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1995431, encodeId=a4701995431c2, content=<a href='/topic/show?id=6a1c2650946' target=_blank style='color:#2F92EE;'>#体制改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26509, encryptionId=6a1c2650946, topicName=体制改革)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Jun 05 11:30:00 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650209, encodeId=6c37165020996, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Tue Jul 25 14:30:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672445, encodeId=a9e616e24453d, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Sun Aug 20 00:30:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408813, encodeId=18191408813be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 11 13:30:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169282, encodeId=28341692829c, content=流通渠道和价格审查的监管很重要!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Tue Jan 10 09:56:45 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169170, encodeId=84181691e089, content=好消息,快点实施, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Jan 09 22:39:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1986989, encodeId=fe0c19869893e, content=<a href='/topic/show?id=006035295f4' target=_blank style='color:#2F92EE;'>#医药卫生体制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35295, encryptionId=006035295f4, topicName=医药卫生体制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Dec 01 20:30:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907285, encodeId=590e190e2857a, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Wed Apr 19 20:30:00 CST 2017, time=2017-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1995431, encodeId=a4701995431c2, content=<a href='/topic/show?id=6a1c2650946' target=_blank style='color:#2F92EE;'>#体制改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26509, encryptionId=6a1c2650946, topicName=体制改革)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Jun 05 11:30:00 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650209, encodeId=6c37165020996, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Tue Jul 25 14:30:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672445, encodeId=a9e616e24453d, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Sun Aug 20 00:30:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408813, encodeId=18191408813be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 11 13:30:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169282, encodeId=28341692829c, content=流通渠道和价格审查的监管很重要!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Tue Jan 10 09:56:45 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169170, encodeId=84181691e089, content=好消息,快点实施, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Jan 09 22:39:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1986989, encodeId=fe0c19869893e, content=<a href='/topic/show?id=006035295f4' target=_blank style='color:#2F92EE;'>#医药卫生体制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35295, encryptionId=006035295f4, topicName=医药卫生体制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Dec 01 20:30:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907285, encodeId=590e190e2857a, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Wed Apr 19 20:30:00 CST 2017, time=2017-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1995431, encodeId=a4701995431c2, content=<a href='/topic/show?id=6a1c2650946' target=_blank style='color:#2F92EE;'>#体制改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26509, encryptionId=6a1c2650946, topicName=体制改革)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Jun 05 11:30:00 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650209, encodeId=6c37165020996, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Tue Jul 25 14:30:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672445, encodeId=a9e616e24453d, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Sun Aug 20 00:30:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408813, encodeId=18191408813be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 11 13:30:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169282, encodeId=28341692829c, content=流通渠道和价格审查的监管很重要!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Tue Jan 10 09:56:45 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169170, encodeId=84181691e089, content=好消息,快点实施, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Jan 09 22:39:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1986989, encodeId=fe0c19869893e, content=<a href='/topic/show?id=006035295f4' target=_blank style='color:#2F92EE;'>#医药卫生体制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35295, encryptionId=006035295f4, topicName=医药卫生体制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Dec 01 20:30:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907285, encodeId=590e190e2857a, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Wed Apr 19 20:30:00 CST 2017, time=2017-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1995431, encodeId=a4701995431c2, content=<a href='/topic/show?id=6a1c2650946' target=_blank style='color:#2F92EE;'>#体制改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26509, encryptionId=6a1c2650946, topicName=体制改革)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Jun 05 11:30:00 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650209, encodeId=6c37165020996, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Tue Jul 25 14:30:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672445, encodeId=a9e616e24453d, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Sun Aug 20 00:30:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408813, encodeId=18191408813be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 11 13:30:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169282, encodeId=28341692829c, content=流通渠道和价格审查的监管很重要!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Tue Jan 10 09:56:45 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169170, encodeId=84181691e089, content=好消息,快点实施, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Jan 09 22:39:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]
    2017-08-20 respect
  6. [GetPortalCommentsPageByObjectIdResponse(id=1986989, encodeId=fe0c19869893e, content=<a href='/topic/show?id=006035295f4' target=_blank style='color:#2F92EE;'>#医药卫生体制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35295, encryptionId=006035295f4, topicName=医药卫生体制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Dec 01 20:30:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907285, encodeId=590e190e2857a, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Wed Apr 19 20:30:00 CST 2017, time=2017-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1995431, encodeId=a4701995431c2, content=<a href='/topic/show?id=6a1c2650946' target=_blank style='color:#2F92EE;'>#体制改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26509, encryptionId=6a1c2650946, topicName=体制改革)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Jun 05 11:30:00 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650209, encodeId=6c37165020996, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Tue Jul 25 14:30:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672445, encodeId=a9e616e24453d, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Sun Aug 20 00:30:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408813, encodeId=18191408813be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 11 13:30:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169282, encodeId=28341692829c, content=流通渠道和价格审查的监管很重要!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Tue Jan 10 09:56:45 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169170, encodeId=84181691e089, content=好消息,快点实施, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Jan 09 22:39:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]
    2017-01-11 cathymary
  7. [GetPortalCommentsPageByObjectIdResponse(id=1986989, encodeId=fe0c19869893e, content=<a href='/topic/show?id=006035295f4' target=_blank style='color:#2F92EE;'>#医药卫生体制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35295, encryptionId=006035295f4, topicName=医药卫生体制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Dec 01 20:30:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907285, encodeId=590e190e2857a, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Wed Apr 19 20:30:00 CST 2017, time=2017-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1995431, encodeId=a4701995431c2, content=<a href='/topic/show?id=6a1c2650946' target=_blank style='color:#2F92EE;'>#体制改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26509, encryptionId=6a1c2650946, topicName=体制改革)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Jun 05 11:30:00 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650209, encodeId=6c37165020996, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Tue Jul 25 14:30:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672445, encodeId=a9e616e24453d, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Sun Aug 20 00:30:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408813, encodeId=18191408813be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 11 13:30:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169282, encodeId=28341692829c, content=流通渠道和价格审查的监管很重要!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Tue Jan 10 09:56:45 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169170, encodeId=84181691e089, content=好消息,快点实施, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Jan 09 22:39:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]
    2017-01-10 1e1e0321m25(暂无匿称)

    流通渠道和价格审查的监管很重要!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1986989, encodeId=fe0c19869893e, content=<a href='/topic/show?id=006035295f4' target=_blank style='color:#2F92EE;'>#医药卫生体制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35295, encryptionId=006035295f4, topicName=医药卫生体制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Dec 01 20:30:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907285, encodeId=590e190e2857a, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Wed Apr 19 20:30:00 CST 2017, time=2017-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1995431, encodeId=a4701995431c2, content=<a href='/topic/show?id=6a1c2650946' target=_blank style='color:#2F92EE;'>#体制改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26509, encryptionId=6a1c2650946, topicName=体制改革)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Jun 05 11:30:00 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650209, encodeId=6c37165020996, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Tue Jul 25 14:30:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672445, encodeId=a9e616e24453d, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Sun Aug 20 00:30:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408813, encodeId=18191408813be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 11 13:30:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169282, encodeId=28341692829c, content=流通渠道和价格审查的监管很重要!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Tue Jan 10 09:56:45 CST 2017, time=2017-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169170, encodeId=84181691e089, content=好消息,快点实施, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Jan 09 22:39:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]
    2017-01-09 有备才能无患

    好消息,快点实施

    0

相关资讯

2016年,国务院开出了这些医改“药方”

导读:为了夯实大家的“幸福之基”,破解“看病难、看病贵”的难题,国务院这一年在医改领域下了不少功夫、出台了多项政策。

国务院医改办新主任已上任!

导语:天津市委常委、宣传部部长王贺胜,调任国家卫计委副主任,并成为新一任的国务院医改办主任。2015年10月,国家卫计委原副主任、国务院医改办主任孙志刚调任贵州,担任贵州省委副书记、省长职务。此后,国务院医改办主任的继任人选一直备受关注。昨日,司徒君从消息人士那里获悉,天津市委常委、宣传部部长王贺胜,调任国家卫计委副主任,并成为新一任的国务院医改办主任,并已经在国家卫计委上班。公开资料显示,王贺胜

国务院总结8年医改成效 将推广多项医改经验

11月8日,中共中央办公厅、国务院办公厅转发了《国务院深化医药卫生体制改革领导小组关于进一步推广深化医药卫生体制改革经验的若干意见》(以下简称《意见》)。《意见》总结了新医改以来所取得的重大进展和明显成效,其核心则是针对各地的典型经验做全国推广。新医改的成效有哪些?新医改的成效可以总结为以下几点:第一,全民医保制度基本建立。基本医疗保险参保率稳固在95%以上,覆盖人口超过13亿人,2016年城

国务院发布2015年度公立医院改革情况七大亮点

导 语  国务院医改办联合5部门共同完成了2015年度公立医院综合改革效果评价考核工作,并形成专项工作报告。

你竟然不知道他!国务院医改领导小组全新人员名单……

导语:10月27日,国务院办公厅发布通知,公布了调整后的,“国务院深化医药卫生体制改革领导小组组成人员”的名单。10月27日,国务院办公厅发布通知,公布了调整后的,“国务院深化医药卫生体制改革领导小组组成人员”的名单。        组 长:刘延东  国务院副总理        副组长:李 斌  卫生计生委主任&nbs

医护人员工资这么低,国务院打算怎么涨?

《国务院深化医药卫生体制改革领导小组关于进一步推广深化医药卫生体制改革经验的若干意见》对医护人员薪酬改革提出了宏观的要求,但并未明确如何改革。地方如何结合实际,公立医院薪酬水平多少才算“合理”? 中国医护人员薪资到底有多低?近日,华医网一项覆盖15761人医护人员的调查结果显示:87%的医生年收入低于10万元,其中43%的医生年收入低于5万元;93%的护士年收入低于10万元,其中55%的

Baidu
map
Baidu
map
Baidu
map